| YICHANG, HUBEI, CHINA--(Marketwire - Feb. 29, 2012) - Hubei Minkang Pharmaceutical Ltd. (OTCBB:HBMK) ("Hubei Minkang" or the "Company") is pleased to announce that its Chinese subsidiary, Hubei Minkang Pharmaceutical Co., Ltd. ("Hubei PRC") has recently signed a Memorandum of Understanding with Henan Wanlong Pharmaceutical Co., Ltd. ("Henan Wanlong") of Zhengzhou, Henan, China with respect to a proposal for Hubei PRC to acquire 51% of Henan Wanlong to expand distribution and increase sales growth. ...continued HBMK |
SmallCapUpdates provides the latest news and alerts on stocks for you. If you are looking for the latest on stocks in clean energy, medical innovation, mining, biotech, nanotech, renewable energy, internet technology or in emerging markets.
Wednesday, February 29, 2012
Hubei Minkang Pharmaceutical Co., Ltd. Signs an MOU with Henan Wanlong Pharmaceutical
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment